Test Price
550 AED✅ Home Collection Available
Gaucher Disease Quantitative Blood Test in UAE | 550 AED | DHA Certified
Executive Summary & Core Metrics
Executive Summary: This Gaucher Disease Quantitative Blood Test provides high diagnostic sensitivity for lysosomal glucocerebrosidase enzyme activity through a fluorometric assay validated against LC-MS/MS reference standards. Processed in our ISO 9001:2015 certified laboratory under DHA/MOHAP oversight, the test delivers accurate enzymatic measurements within 4 calendar days. Patients benefit from VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM, with post-test telephonic clinical guidance provided by our genetics team. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This quantitative blood test measures glucocerebrosidase enzyme activity in peripheral whole blood to diagnose Gaucher disease, an autosomal recessive lysosomal storage disorder. The assay employs fluorometric substrate cleavage monitored by tandem mass spectrometry, delivering precise enzymatic levels with a rapid 4-day turnaround to enable early detection and informed therapeutic management.
| Feature | Our Test (Gaucher Quantitative) | Closest Alternative (Standard Enzymatic) |
|---|---|---|
| Precision | Fluorometric Enzyme Assay (LC-MS/MS validated) | Colorimetric or low-sensitivity assay |
| Methodology | ISO 9001:2015 Certified; DHA/MOHAP standardized | Variable, often non-accredited |
| Speed (Report TAT) | 4 Days (Sample by 4 pm daily) | 5–10 Days |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics licensed by DHA (9294403), I emphasize that the quantitative glucocerebrosidase enzyme assay is a critical first-line test for confirming Gaucher disease, yet it must be interpreted alongside molecular genetic analysis and comprehensive clinical evaluation. Enzyme activity levels can be influenced by sample handling, anticoagulant interference, and concomitant therapies. Patients should not alter or discontinue prescribed medication without explicit consultation with their treating physician. Confirmatory genetic sequencing of the GBA1 gene is recommended for definitive diagnosis and family counseling.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics
Advisory Precautions for Safe Testing
Patients undergoing anticoagulant therapy must have their INR verified prior to venipuncture to reduce hematoma risk. Maintain normal hydration and avoid aspirin or NSAIDs for 48 hours before collection. The sample must be drawn into three cold EDTA or heparin tubes and shipped immediately under refrigerated conditions. Hemolysis, delayed transport, or improper temperature storage may invalidate results and require redraw.
Exclusion Criteria & Red Flags
- Patients on anticoagulant therapy with improperly managed INR (risk of hematoma during blood draw).
- Sample hemolysis, improper refrigeration, or freezing will lead to test cancellation and request for recollection.
- Emergency red flags: If you experience acute bone pain, unexplained bleeding, or sudden neurological deterioration, seek immediate emergency care. This test is not a substitute for urgent medical assessment.
Patient FAQ & Clinical Guidance
1. What is the purpose of the Gaucher Disease Quantitative Blood Test?
Snippet: The test quantifies glucocerebrosidase enzyme activity in blood to diagnose Gaucher disease, a genetic lysosomal storage disorder, enabling targeted therapy decisions and family risk assessment.
2. How should I prepare for the sample collection?
Snippet: Maintain normal hydration, avoid aspirin and NSAIDs for 48 hours, and ensure the sample is drawn into three cold EDTA or heparin tubes shipped refrigerated immediately. Our mobile phlebotomist will coordinate collection timing and transport logistics.
3. What do low enzyme activity results indicate?
Snippet: Glucocerebrosidase activity below the established reference range strongly suggests Gaucher disease and necessitates confirmatory genetic testing (GBA1 sequencing) and consultation with a medical genetics specialist for definitive diagnosis and management planning.
4. Is home sample collection available for this test?
Snippet: Yes, VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection is available daily from 8 AM to 11 PM across Dubai and the Northern Emirates. A trained phlebotomist will visit your residence or office, collect the required blood samples, and ensure proper refrigerated transport to our ISO 9001:2015 certified laboratory.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data, including enzymatic assay results and genetic information, are encrypted, access-controlled, and processed exclusively within UAE data centers. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring transparent pre-test counseling and documented informed consent. Our DHA-licensed facility (License No. 1143) is subject to annual audit and maintains strict chain-of-custody for all biological specimens.
Clinical & Logistical Metadata
| Test Name | Gaucher Disease Quantitative Blood Test (Glucocerebrosidase Enzyme Activity) |
| Price (AED) | 550 AED |
| Turnaround Time | 4 Calendar Days (sample by 4 pm daily) |
| Sample Type / Matrix | Peripheral whole blood (venous draw) — VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Fluorometric Enzyme Assay (LC-MS/MS validated) under ISO 9001:2015 certification |
| ICD-10-CM Code | E75.22 (Gaucher disease) |
| LOINC Code | 48173-2 (Glucocerebrosidase [Enzymatic activity/mass] in Blood) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians